| Financial Year |
March 31 2023 |
| Monetary Funds |
2,292,609,362.29 |
| Held-for-trading Financial Assets |
701,715,972.22 |
| Notes Receivable |
-- |
| Accounts Receivable |
314,416,157.31 |
| Advances to Suppliers |
22,643,115.64 |
| Other Receivables |
76,975,543.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
652,798,044.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
315,850,351.33 |
| Total Current Assets |
4,523,777,433.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
448,554,998.66 |
| Under-construction Projects |
75,848,832.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
339,252,969.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
109,365,603.07 |
| Deferred Income Tax Assets |
99,205,638.47 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,362,221,921.12 |
| Total Assets |
5,885,999,354.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,980,023.19 |
| Accounts Payable |
232,394,934.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
86,556,318.43 |
| Taxes Payable |
205,630,561.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
112,652,472.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
184,553,239.29 |
| Other Current Liabilities |
295,444,494.31 |
| Sub-Total of Current Liabilities |
1,300,341,366.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,363,326.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
152,413,734.25 |
| Total Liabilities |
1,452,755,100.59 |
| Paid-In Capital(Or Share Stock) |
570,707,084.00 |
| Capital Surplus |
893,544,757.34 |
| Surplus Reserve |
285,353,542.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,639,659,752.15 |
| Minority Stockholder's Interest |
2,545,301.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,430,698,951.77 |
| Owner's Equity（Stockholder's Equity） |
4,433,244,253.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,885,999,354.18 |
